RxDoctor Payments Data

Nisida Berberi

Neurology with Special Qualifications in Child Neurology · New York, NYNPI 1942596630

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,201 of the $3,008 with a category attached, or 73.1%. 21 manufacturers reported payments, led by Livanova USA, Inc. at 44.0% of the total.

$3,008in general payments, 2019–2025

Across 73 payments — averaging $41.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$1K
  • UCB, Inc.$624
  • Immedica Pharma US, Inc.$211
  • Sumitomo Pharma America, Inc.$126
  • Neurelis, Inc.$114
  • Otsuka America Pharmaceutical, Inc.$104
  • plus $505 from 15 others

What the payments were for

  • Consulting fees$80027%
  • Food & beverage$2,20173%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,008 in reported general payments places this provider in the 75th percentile of 161 neurology with special qualifications in child neurology providers in New York.

See all neurology with special qualifications in child neurology providers in New York

Other neurology with special qualifications in child neurology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →